gastric-cancer

Documents about gastric-cancer

• CT semantic features of primary gastric cancer: a preoperative predictive model for peritoneal metastasis with superior efficacy to conventional direct CT assessment.#251089NCBI PubMed Central
• An integrated network toxicology and multi-omics study identifies ENO1 as a candidate mediator in benzo[a]pyrene-related gastric cancer progression.#368191NCBI PubMed Central
• The Surgical Assessment and Healthcare (SAH) Index: A Risk-Adjusted Framework for Surgeon-Level Quality Audit in Gastric Cancer#381667bioRxiv / medRxiv
• Novel Targeted Agents For Gastric Cancer#412849OpenCitations
• Benefit of Linked-Color Imaging in Artificial Intelligence-Assisted Diagnosis of Early Gastric Cancer: A Pilot Study With Propensity Score Adjustment.#419074PubMed
• Integrated Single-Cell and Spatial Transcriptomics Reveal SERPINE1 as a Key Link Between Macro_SPP1 Macrophages and Stromal Remodeling in Gastric Cancer.#662730NCBI PubMed Central
• Advanced GC Multi-omic Characterization in EU and CELAC Populations#810079ClinicalTrials.gov
• Minimally Invasive Surgery (MIS) Database for the Purpose of Research#827280ClinicalTrials.gov
• Laparoscopy-assisted Proximal Gastrectomy Versus and Laparoscopy-assisted Total Gastrectomy#832188ClinicalTrials.gov
• Early Recovery After Surgery (ERAS) Versus Conventional Protocol After Laparoscopic Gastrectomy#904371ClinicalTrials.gov
• The Effect of Different Digestive Tract Reconstruction Methods on Postoperative Quality of Life After Proximal Gastrectomy#844910ClinicalTrials.gov
• Combination of COMBO Endoscopy Oropharyngeal Airway and HFNC Oxygenation in Sedated Gastrointestinal Endoscopy for Morbidly Obese Patients#885607ClinicalTrials.gov
• Ropidoxuridine in Treating Patients With Advanced Gastrointestinal Cancer Undergoing Radiation Therapy#854918ClinicalTrials.gov
• Genetic Variants of Peroxisome Proliferator-Activated Receptor δ Are Associated with Gastric Cancer#780446eScholarship
• Anti-Ly6E Exatecan ADC M7437 in Advanced Solid Tumors#876209ClinicalTrials.gov
• Early prediction of skeletal muscle loss using longitudinal clinical data in patients with gastric cancer after radical gastrectomy and adjuvant chemotherapy: a retrospective cohort study#238050bioRxiv / medRxiv
• The research progress of the synergistic effect of Epstein-Barr virus and Helicobacter pylori infection in the occurrence and development of gastric cancer.#457508NCBI PubMed Central
• Differential T cell clonal dynamics underlie outcomes to frontline chemoimmunotherapy in advanced gastric cancer#485100Europe PMC
• Knowledge, beliefs, perceived barriers, and previous upper gastrointestinal endoscopy use regarding Helicobacter pylori and gastric cancer prevention among community residents: a cross-sectional study.#613328NCBI PubMed Central
• Difference in H. Pylori Infection Rate of EGC Patients Before and After Endoscopic Resection#841083ClinicalTrials.gov
• Usefulness of Serum Pepsinogen and Gastrin as the Predictive Biomarker of Atrophic Gastritis, Intestinal Metaplasia and Gastric Cancer in Korea#879294ClinicalTrials.gov
• Comparing the Safety and Efficacy of First-line Polychemotherapy and Polychemotherapy in Combination With PIPAC Sessions#907516ClinicalTrials.gov
• Real-World Evaluation of an AI-Assisted Diagnostic Support System for Early Gastric Cancer: Diagnostic Performance, Confidence Stratification, and Determinants of False-Positive Diagnosis.#12791NCBI PubMed Central
• Synthesis of Cytotoxic Iron-Containing Macrocycles Through Unexpected C(sp2) C(sp2) Bonds Formation#31441HAL (France)
• Single-cell atlas of gastric cancer reveals malignant epithelial evolution and regulatory reprogramming of the tumor microenvironment#126099PLOS
• Single-Cell sequencing investigation of endoplasmic reticulum stress-related genes in gastric cancer prognostic models and identification of NOX5 as a novel therapeutic target.#143198NCBI PubMed Central
• Estimated five-year survival and direct healthcare costs of adult patients with gastric cancer: real-world evidence from a tertiary hospital in Colombia.#345323NCBI PubMed Central
• Cost-effectiveness analysis of trastuzumab deruxtecan versus ramucirumab plus paclitaxel as second-line treatment for HER2-positive metastatic gastric cancer or gastroesophageal junction adenocarcinoma.#358567NCBI PubMed Central
• Supplementary Figures and Tables for <b>Blood and Gut Virome Remodeling in Gastric Cancer: Anellovirus Expansion and Novel Virus Discovery</b>#359866Figshare
• Multiscale Spatial Fusion Feature-Driven Characterization of Gastric Cancer Invasive Margins: A Multicenter Cohort Study for Preoperative Accurate Differentiation Between T4a and T4b Subtypes.#388703NCBI PubMed Central
• Continuous Infusion of FU Combined With Epirubicin and Oxaliplatin in Patients With A/MGC#868884ClinicalTrials.gov
• Pressurized Intraperitoneal Aerosol Chemotherapy (PIPAC) With Oxaliplatin In Patients With Peritoneal Carcinomatosis#967631ClinicalTrials.gov
• Tislelizumab Plus Chemotherapy as Postoperative Adjuvant Therapy in Elderly Patients With LA GC/GEJC#1007389ClinicalTrials.gov
• Comparison Between High-dose Amoxicillin Dual Therapy and Pylera Quadruple Therapy in the Treatment of Helicobacter Pylori Infection#123493ClinicalTrials.gov
• Safety and Tolerability Evaluation Study of BVAC-B in Patients With HER2/Neu(Human Epithelial Growth Factor Receptor 2) Positive Gastric Cancer After Failure to Standard Care#125953ClinicalTrials.gov
• Curability difference between autochthonous mouse tumors and their transplants in association with immune gene expression#127888PLOS
• Deep Learning Model Based on Tumor and Visceral Adipose Tissue CT Features for Predicting Peritoneal Metastasis Risk after Radical Gastrectomy in Serosa-Invasive Gastric Cancer.#258151NCBI PubMed Central
• The Farnesoid X receptor-bile acid axis contributes to immune evasion in gastric cancer and its inhibition enhances efficacy of anti-PD-L1 therapy.#266983NCBI PubMed Central
• Characterization and functional analysis of miRNAs in <i>Salvia miltiorrhiza</i>-isolated exosome-like nanoparticles for gastric cancer treatment#376008PLOS
• Predictive value of the preoperative controlling nutritional status score for anastomotic leakage after radical gastrectomy for gastric cancer and risk stratification based on predicted probability.#610301NCBI PubMed Central
• Gastric amyloid pathology and mucosal denervation in ATTRv amyloidosis: insights from patients, mice, and gut microenvironment profiles#612326Figshare
• Whole Course Multi-model Prehabilitation to Improve Clinical Outcome in Patients Undergoing Neoadjuvant Treatment Prior to Gastrectomy#841338ClinicalTrials.gov
• Psychological, Psychophysical and Epigenetic Determinants of Chronic Pain After Cytoreductive - Hyperthermic Intraoperative Chemotherapy#842642ClinicalTrials.gov
• A Study to Test Different Doses of BI 765049 in People With Advanced Cancer of the Colon, Rectum, Stomach, or Pancreas#883995ClinicalTrials.gov
• Assessment of Robotic Versus Laparoscopic Gastrectomy for GC Patients With Intraoperative Technical Complexity#1007909ClinicalTrials.gov
• Post Hoc Analysis of the Phase II DESTINY-PanTumor02 Study: Local and Central HER2 IHC Concordance and Trastuzumab Deruxtecan Efficacy by HER2 IHC Status in HER2-Expressing Solid Tumors#428711S-Space: Seoul National University
• A Clinical Trial to Test if the Investigational Drug BNT329 is Safe and Potentially Beneficial for People With Advanced Solid Tumors Known to Express the Tumor Marker CA19-9#888748ClinicalTrials.gov
• A Phase I Interventional Open-label, Non-randomized Dose-escalation Trial to Evaluate the Safety, Tolerability, Pharmacokinetics, Pharmacodynamics, Immunogenicity, and Preliminary Anti-tumor Activity of Autologous p95HER2.CAR-TECH2Me T Cells in Patients With Selected Advanced Cancers.#831884ClinicalTrials.gov
• Safety of FOLFIRI + Durvalumab +/− Tremelimumab in Second Line of Patients with Advanced Gastric Cancer: A Safety Run-In from the Randomized Phase II Study DURIGAST PRODIGE 59#322415HAL (France)
• Integrated Bulk and Single-Cell Transcriptomic Analyses Identify a Five-Gene Signature Associated With Prognosis and the Tumor Microenvironment in Epstein-Barr Virus-Associated Gastric Cancer.#621046NCBI PubMed Central